Sunmax Biotechnology Co., Ltd. (TPEX: 4728)
Taiwan
· Delayed Price · Currency is TWD 273.00
-5.00 (-1.80%)
Sep 10, 2024, 11:11 AM CST
Sunmax Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 711.78 | 625.71 | 533.83 | 245.64 | 238.08 | 100.45 | Upgrade
|
| Depreciation & Amortization | 88.23 | 72.83 | 58.15 | 55.76 | 33.8 | 14 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.14 | 0.13 | -0.46 | 2.1 | -1.34 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 8.32 | -1.91 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -0.39 | 0.24 | -2.38 | 2.46 | Upgrade
|
| Other Operating Activities | -5.93 | 17.96 | 42.52 | 18.34 | -1.97 | 22.49 | Upgrade
|
| Change in Accounts Receivable | -0.07 | -0.23 | 3.34 | 1.81 | 12.81 | -10.29 | Upgrade
|
| Change in Inventory | -48.54 | -19.88 | -19.05 | -29.41 | 6.1 | -18.01 | Upgrade
|
| Change in Accounts Payable | -4.84 | -7.61 | 9.46 | 3.58 | -3.34 | 2.12 | Upgrade
|
| Change in Unearned Revenue | -79.07 | 142.48 | -62.86 | 11.01 | 50.81 | 154.85 | Upgrade
|
| Change in Other Net Operating Assets | -15.53 | 17.17 | 80.03 | -65.8 | 46.09 | 23.34 | Upgrade
|
| Operating Cash Flow | 646.17 | 848.56 | 644.57 | 243.28 | 386.97 | 289.51 | Upgrade
|
| Operating Cash Flow Growth | -12.76% | 31.65% | 164.95% | -37.13% | 33.67% | 187.12% | Upgrade
|
| Capital Expenditures | -88.44 | -107.66 | -154.58 | -253.02 | -129.87 | -13.68 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.42 | 0.42 | 0.51 | 3.1 | 0.61 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -3.4 | -2.73 | -0.59 | -2.4 | -0.23 | - | Upgrade
|
| Investment in Securities | 76.83 | 125 | -136.43 | 39.68 | 28.88 | 102.37 | Upgrade
|
| Other Investing Activities | -16.33 | -30.1 | -85.53 | -72.53 | -1.29 | -6.51 | Upgrade
|
| Investing Cash Flow | -31.88 | -16.04 | -376.62 | -285.17 | -101.9 | 82.18 | Upgrade
|
| Long-Term Debt Repaid | - | -22.97 | -39.16 | -24.39 | -14.81 | -34.05 | Upgrade
|
| Net Debt Issued (Repaid) | -27.58 | -22.97 | -39.16 | -24.39 | -14.81 | -34.05 | Upgrade
|
| Common Dividends Paid | -517.4 | -517.4 | -239.64 | -108.93 | -81.7 | -65.36 | Upgrade
|
| Other Financing Activities | 0.47 | -9.43 | -2.41 | 1.35 | 1.13 | 2.82 | Upgrade
|
| Financing Cash Flow | -544.51 | -549.8 | -281.21 | -131.97 | -95.38 | -96.59 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.21 | -17.33 | 0.01 | -2.18 | 5.39 | -5.94 | Upgrade
|
| Net Cash Flow | 70 | 265.39 | -13.25 | -176.03 | 195.09 | 269.16 | Upgrade
|
| Free Cash Flow | 557.73 | 740.9 | 489.99 | -9.74 | 257.11 | 275.82 | Upgrade
|
| Free Cash Flow Growth | -14.29% | 51.21% | - | - | -6.79% | 186.98% | Upgrade
|
| Free Cash Flow Margin | 31.69% | 43.87% | 35.00% | -0.94% | 30.04% | 46.42% | Upgrade
|
| Free Cash Flow Per Share | 10.23 | 13.59 | 8.98 | -0.18 | 4.71 | 5.06 | Upgrade
|
| Cash Interest Paid | 5.33 | 2.94 | 1.35 | 2.81 | 2.92 | 2.74 | Upgrade
|
| Cash Income Tax Paid | 266.35 | 259.68 | 199.74 | 92.59 | 100.69 | 30.16 | Upgrade
|
| Levered Free Cash Flow | 446.61 | 612.07 | 412.52 | 7.73 | 152.81 | 284.61 | Upgrade
|
| Unlevered Free Cash Flow | 449.94 | 613.91 | 413.36 | 9.48 | 154.63 | 286.32 | Upgrade
|
| Change in Net Working Capital | 133 | -92.23 | -30.39 | 20.46 | -43.23 | -176.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.